Treatment with pexelizumab, a monoclonal antibody against the C5 complement component, does not prevent the overall drop in cognition that can occur after...
The 90-day incidence of stroke in stabilized patients with acute coronary syndrome (ACS) is just 0.71%, according to a new report. However, most of the strokes...
In patients with acute coronary syndromes (ACS) lacking ST-segment elevation, early revascularization is associated with a significant reduction in 1-year...
The U.S. Centers for Medicare and Medicaid Services (CMS) on Wednesday issued a long-awaited coverage decision proposal that significantly expands Medicare...
New research suggests that diabetes accelerates the progression of rigidity and gait disturbances in older persons. In contrast, the endocrine disease does not...
Chronic insulin therapy significantly increases the risk of colorectal cancer (CRC) in patients with type 2 diabetes mellitus (DM), according to the results of...
Botulinium toxin injection of the pylorus is safe and significantly improves symptoms of nausea and vomiting in patients with diabetic gastroparesis, according...
Among uremic patients with type 1 diabetes, multiple hemostatic abnormalities revert to normal after kidney-pancreas transplantation, according to a report in...
Treatment with pexelizumab, a monoclonal antibody against the C5 complement component, does not prevent the overall drop in cognition that can occur after...
The new 2004 guidelines for the management of hypertension from the British Hypertension Society (BHS)[1] should further change primary care practice, which is...
Lifestyle Changes. The importance of lifestyle change can often be neglected in the excitement to discuss targets and treatments. Once again, the BHS...
Patient Participation. The BHS guidelines note that "a vital aspect of the successful management and control of high blood pressure is to obtain the...
The recent EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) examined the effect of treatment with the...
Bradycardia or bradyarrhythmia in adults may be considered present if the heart rate is <60 beats/min in the setting of sinus rhythm, a variety of atrial...
Since many of the cardioactive and antiarrhythmic drugs have a depressant effect on sinus node automaticity and atrioventricular nodal (AVN) conduction, sinus...
There are no data in the literature regarding incidence of drug induced bradycardia in specific cardiac conditions. According to a review of 26 published...
Rapid Atrial Tachyarrhythmias The following situations are involved in the induction of bradycardia by drugs generally used for rate and/or rhythm control ...
There are no controlled studies addressing the guidelines for the management of drug induced bradycardia and the indications for pacing. Nevertheless, the...
Six months after undergoing emergency bone marrow stem cell (BMC) transplantation, myocardial infarction (MI) patients had enhanced left ventricular function...
In its first pilot study, a remote control percutaneous coronary intervention (PCI) system (made by NaviCath Ltd.) helped to reduce operator-based errors,...
High blood pressure is likely to cause cognitive decline in young people as well as old, according to the results of a longitudinal study published in the Oct....
In patients with hypertension, hypercholesterolemia, and insulin resistance, amlodipine and atorvastatin together improve fibrinolytic balance and blood...
A mutation in a widely expressed calcium channel gene appears to be responsible for a novel multisystem disorder -- Timothy syndrome -- characterized by lethal...
Restoring the normal elliptical shape to the left ventricle with surgery improves cardiac function in patients with post-anterior infarction congestive heart...
Esterified estrogen is not linked to increased risk of venous thrombosis, according to the results of a population-based, case- control study published in the...
Blood transfusion in patients with acute coronary syndrome (ACS) is associated with an increased risk of 30-day mortality, according to the results of a...
The new MATRIX Biolimus A9-eluting stent appears to be a promising antirestenosis therapy. In its first human study, Biolimus A9 was shown to be safe without...
Merck & Co., Inc., announced today a voluntary withdrawal of rofecoxib (Vioxx) from the U.S. and worldwide market due to safety concerns of an increased risk...
Repressing the c-Jun N-terminal kinase (JNK) pathway by means of a cell-permeable inhibitory peptide may be of use in diabetes therapy, Japanese researchers...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
